As Research Into Pain Accelerates, A Newly Recognized Type Of Pain Comes To The Forefront Tonix Targets It With FDA-Fast Track-Designated TNX-102 SL
| TNXP Stock | USD 0.61 0.04 7.02% |
Slightly above 55% of Tonix Pharmaceuticals' retail investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Tonix Pharmaceuticals Holding suggests that some traders are interested. Tonix Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Tonix Pharmaceuticals Holding. Many technical investors use Tonix Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Tonix |
Read at benzinga.com
 |
Tonix Pharmaceuticals Fundamental Analysis
We analyze Tonix Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tonix Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tonix Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Tonix Pharmaceuticals is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Tonix Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tonix Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Tonix Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tonix Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Tonix Pharmaceuticals Related Equities
| JAGX | Jaguar Animal | 6.90 | ||||
| VXRT | Vaxart | 3.33 | ||||
| IBIO | Ibio | 2.48 | ||||
| NVAX | Novavax | 0.23 | ||||
| INO | Inovio Pharmaceuticals | 0.54 | ||||
| DRUG | Bright Minds | 1.18 | ||||
| SONN | Sonnet Biotherapeutics | 1.89 | ||||
| PALI | Palisade Bio | 2.78 | ||||
| VRAX | Virax Biolabs | 7.41 | ||||
| ENVB | Enveric Biosciences | 10.81 |
Additional Tools for Tonix Stock Analysis
When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.